Tacrolimus in dermatology

Journal of Cutaneous Medicine and Surgery
Q H Dé TranJ Tousignant

Abstract

Tacrolimus (FK 506), a metabolite of the fungus Streptomyces tsukubaensis, is an anti-T-cell drug. It acts by inhibiting the production of IL-2, IL-3, IL-4, TNFa, and GM-CSF. More potent and with slightly less secondary effects than cyclosporine, it has been the object of considerable interest, especially in conditions that could benefit from the latter. In psoriasis, a placebo-controlled double-blind study has shown oral tacrolimus at 0.1 mg/kg/day to be effective in controlling recalcitrant lesions. In human, small studies have reported tacrolimus ointment to be effective in controlling acute contact dermatitis. Short-term trials of topical tacrolimus in the treatment of atopic dermatitis have recently shown excellent results in both adults and children. In animal studies of hair growth disorders, topical tacrolimus induces anagen and protects from chemotherapy-induced alopecia. Animal studies with the ointment for the prevention of skin graft rejection, lupus dermatoses, and skin papilloma formation have also shown to be promising. There are case reports of pyoderma gangrenosum, Sezary's syndrome, and Behcet's disease successfully treated with oral tacrolimus but, because of their small number, they remain anecdotal at this ...Continue Reading

Citations

Sep 16, 2010·Clinical Rheumatology·Iliana AlexoudiGeorge Vaiopoulos
Mar 9, 2011·Biologics : Targets & Therapy·Michael Sticherling
Oct 16, 2004·The Journal of Investigative Dermatology·John A Carucci
May 26, 2007·Transplantation Proceedings·H KaaroudA Kheder
Oct 20, 2004·The British Journal of Dermatology·J WenzelT Tüting
Jun 25, 2004·The British Journal of Dermatology·D Wilsmann-TheisN Novak
May 20, 2003·The British Journal of Dermatology·G VecchiettiL Borradori
Nov 16, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Joerg WenzelThomas Tüting
Nov 1, 2007·Dermatologic Therapy·V Madan, C E M Griffiths
Nov 4, 2004·Journal of the American Academy of Dermatology·Mark LebwohlUNKNOWN Tacrolimus Ointment Study Group
Jun 22, 2005·Survey of Ophthalmology·Cem Evereklioglu
Dec 3, 2003·Seminars in Cutaneous Medicine and Surgery·John A Carucci
Apr 18, 2007·Cell Transplantation·Gaston M PonteRodolfo Alejandro
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Cem Evereklioglu
Dec 2, 2017·Pediatric Dermatology·Stephanie R Jackson Cullison, Elaine C Siegfried
Jan 11, 2021·Journal of the American Academy of Dermatology·Ha Eun KongTravis W Blalock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.